<img src="//bat.bing.com/action/0?ti=5189112&amp;Ver=2" height="0" width="0" style="display:none; visibility: hidden;">

    Products Liability Law Legal Research Blog

    PRODUCTS LIABILITY: U.S. District Court Upholds Award of $21 Million Against Manufacturer of Anti-Inflammatory Drug

    Posted by Gale Burns on Mon, Jan 17, 2011 @ 12:01 PM

    January 18, 2011

    Jeremy Taylor, Senior Attorney, National Legal Research Group

    A recent decision by the U.S. District Court for the District of New Hampshire addressed a number of issues regarding defective design of an anti-inflammatory drug, in upholding a jury verdict of over $21 million in favor of the plaintiff.  See Bartlett v. Mut. Pharm. Co., Civ. No. 08‑cv‑358‑JL, 2011 DNH 004 (D.N.H. Jan. 5, 2011).  The plaintiff alleged that her use of the defendant's drug "sulindac" had caused her to suffer severe and permanent injuries, including blindness.  Specifically, the plaintiff had contracted Stevens-Johnson Syndrome ("SJS"), progressing to toxic epidermal necrolysis ("TEN"), as a result of her use of sulindac.  The plaintiff asserted claims of strict liability for defective design, strict liability for failure to warn, fraud, and negligence under state law.  The district court granted the manufacturer's motion for summary judgment on all but the plaintiff's defective design claim, which was the sole cause of action proceeding to trial.  The jury found in the plaintiff's favor and awarded her $21.06 million in compensatory damages, including $16.5 million for pain and suffering.  Following the verdict, the defendant manufacturer renewed its motion for judgment as a matter of law under Federal Rule of Civil Procedure 50(b), arguing that there was insufficient evidence to support the plaintiff's claim.

    Read More

    Topics: legal research, products liability, defective design, Mutual Pharmaceuticals Company, compensatory damages, risk/benefit test

    PRODUCTS LIABILITY: Exception in State Statute Providing Defense Based upon FDA Approval of Labeling Not Preempted

    Posted by Gale Burns on Fri, Jan 7, 2011 @ 15:01 PM

    November 9, 2010

    Read More

    Topics: legal research, products liability, Jeremy Taylor, federal preemption, FDCA, conflict with state tort law, defense to liability

    New Call-to-action
    Free Hour of Legal Research  for New Clients
    Seven ways outsourcing your legal research can empower your practice